Inventor
ENLOW ELIZABETH
US14 patents
Patents
14 patentsUS9790232B2Oct 17, 2017
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC12 citations92
US9458169B2Oct 4, 2016
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC22 citations89
US10160765B2Dec 25, 2018
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC7 citations82
US9212145B2Dec 15, 2015
Urea derivatives and uses thereof
KALA PHARMACEUTICALS INC3 citations73
US10618906B2Apr 14, 2020
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC2 citations71
US9688688B2Jun 27, 2017
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
KALA PHARMACEUTICALS INC2 citations71
US9393213B2Jul 19, 2016
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC2 citations62
US11713323B2Aug 1, 2023
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations60
US10975090B2Apr 13, 2021
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations60
US10875857B2Dec 29, 2020
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
KALA PHARMACEUTICALS INC0 citations51
US10174022B2Jan 8, 2019
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
KALA PHARMACEUTICALS INC0 citations51
US9393212B2Jul 19, 2016
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC0 citations51
US9890173B2Feb 13, 2018
Crystalline forms of therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations50
US10253045B2Apr 9, 2019
Crystalline forms of a therapeutic compound and uses thereof
KALA PHARMACEUTICALS INC0 citations45